❌

Reading view

F.T.C. Settles With Express Scripts Over High Insulin Prices

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices.

Β© Sarah Holm/The Virginian-Pilot, via Associated Press

High insulin prices generated public outcry for years, though changes in the past few years have reduced patients’ costs to no more than $35 a month in most cases.
  •  

Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers

At two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of medical care for consumers.

Β© Kylie Cooper/Reuters

Stephen Hemsley, chief executive of UnitedHealth Group, left, defended insurers’ practices, along with other companies’ executives, during congressional hearings on Thursday.
  •  

Kaiser Permanente Agrees to Pay $556 Million to Settle Medicare Overbilling Claims

The Justice Department and whistle-blowers accused the major health insurer of overbilling the government for about $1 billion under the private plans.

Β© Rachel Woolf for The New York Times

Dr. James Taylor, a physician and coding expert who worked for Kaiser Permanente, was one of the whistle-blowers who flagged the overbilling. β€œThe cash monster was insatiable,” he said.
  •